Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (211-220 of 393) with videos related to

Pageof 40
Sort By:
Human Pathology|February 9, 2013
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisionsJesse S Voss, Leonard M Holtegaard, Sarah E Kerr, et al.
Cancers|April 3, 2021
Aspirin and Statin Use and the Risk of Gallbladder CancerKritika Prasai, Sri Harsha Tella, Siddhartha Yadav, et al.
Plos One|November 4, 2015
Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF SignalingIkuo Nakamura, Kais Zakharia, Bubu A Banini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
A Novel Clinically Based Staging System for Gallbladder CancerSiddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, et al.
Journal of Molecular Biomarkers & Diagnosis|August 1, 2014
Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary CancerJohn B Kisiel, Jia Li, Hongzhi Zou, et al.
Clinical Epigenetics|October 23, 2019
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinomaYinan Zheng, Ryan A Hlady, Brian T Joyce, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
Mayo Clinic Proceedings|January 4, 2012
Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008Ju Dong Yang, Bohyun Kim, Schuyler O Sanderson, et al.
Hepatology (Baltimore, Md.)|March 18, 2021
Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2-Platelet-Derived Growth Factor Receptor Beta-Yes-Associated Protein Signaling AxisXin Luo, Nellie A Campbell, Li He, et al.
Human Pathology|September 30, 2021
Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classificationMichael Torbenson, Chantal E McCabe, Daniel R O'Brien, et al.
Pageof 40

Showing results (211-220 of 393) with videos related to

Sort By:
Pageof 40
Human Pathology|February 9, 2013
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisionsJesse S Voss, Leonard M Holtegaard, Sarah E Kerr, et al.
Cancers|April 3, 2021
Aspirin and Statin Use and the Risk of Gallbladder CancerKritika Prasai, Sri Harsha Tella, Siddhartha Yadav, et al.
Plos One|November 4, 2015
Correction: Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF SignalingIkuo Nakamura, Kais Zakharia, Bubu A Banini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
A Novel Clinically Based Staging System for Gallbladder CancerSiddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, et al.
Journal of Molecular Biomarkers & Diagnosis|August 1, 2014
Methylated Bone Morphogenetic Protein 3 (BMP3) Gene: Evaluation of Tumor Suppressor Function and Biomarker Potential in Biliary CancerJohn B Kisiel, Jia Li, Hongzhi Zou, et al.
Clinical Epigenetics|October 23, 2019
DNA methylation of individual repetitive elements in hepatitis C virus infection-induced hepatocellular carcinomaYinan Zheng, Ryan A Hlady, Brian T Joyce, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
Mayo Clinic Proceedings|January 4, 2012
Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008Ju Dong Yang, Bohyun Kim, Schuyler O Sanderson, et al.
Hepatology (Baltimore, Md.)|March 18, 2021
Sulfatase 2 (SULF2) Monoclonal Antibody 5D5 Suppresses Human Cholangiocarcinoma Xenograft Growth Through Regulation of a SULF2-Platelet-Derived Growth Factor Receptor Beta-Yes-Associated Protein Signaling AxisXin Luo, Nellie A Campbell, Li He, et al.
Human Pathology|September 30, 2021
Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classificationMichael Torbenson, Chantal E McCabe, Daniel R O'Brien, et al.
Pageof 40